Study attempts to find out how India made expensive diabetes medicines affordable
Diabetes researchers find that India keeps expensive diabetes drugs affordable through its large pharmaceutical export sector and laws that curb patent evergreening while permitting generic manufacturing. The study, cited by The Hindu, notes that these regulatory measures help maintain low prices for insulin and oral hypoglycemics compared with many other countries in the global market.